The acetaminophen-opioid combination market is estimated at USD 3.4 billion in 2026, is projected to reach USD 5.0 billion by 2036 and is forecast to register a 3.9% CAGR between 2026 and 2036. In 2026, tablets hold 76.4% of dosage form sales and acute pain represents 58.5% within the indication segment.